Yuan‐Hung Kuo, Chao‐Hung Hung. Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma—A Step Toward Mechanism‐Guided Second‐Line Therapy. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.70604. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.70604?af=R
Yuan‐Hung Kuo & Chao‐Hung Hung (2026). Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma—A Step Toward Mechanism‐Guided Second‐Line Therapy. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.70604
Yuan‐Hung Kuo and Chao‐Hung Hung. “Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma—A Step Toward Mechanism‐Guided Second‐Line Therapy.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.70604.
@article{Kuo2026,
title = {Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma—A Step Toward Mechanism‐Guided Second‐Line Therapy},
author = {Kuo, Yuan‐Hung and Hung, Chao‐Hung},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.70604},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.70604?af=R}
}